BW-40202

· Shanghai Argo Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BW-40202, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers [Phase 1]